# A Pharmacokinetic and Pharmacodynamic Evaluation of Cytisine in Healthy Smokers

> **NCT03303911** · PHASE1,PHASE2 · TERMINATED · sponsor: **Achieve Life Sciences** · enrollment: 26 (actual)

## Conditions studied

- Smoking Cessation

## Interventions

- **DRUG:** Cytisine

## Key facts

- **NCT ID:** NCT03303911
- **Lead sponsor:** Achieve Life Sciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-10-06
- **Primary completion:** 2018-10-05
- **Final completion:** 2018-10-05
- **Target enrollment:** 26 (ACTUAL)
- **Why stopped:** It has been difficult to recruit participants meeting study entry criteria that are \>65 years of age and not for any safety reasons.
- **Last updated:** 2019-10-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03303911

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03303911, "A Pharmacokinetic and Pharmacodynamic Evaluation of Cytisine in Healthy Smokers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03303911. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*